Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients-Reference-Cited by-同舟云学术

Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients

Published:2019-12 Issue:6 Volume:34 Page:387-395
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Lee Nora,Maeda Kazuya,Fukizawa Shinya,Ieiri Ichiro,Tomaru Atsuko,Akao Hironobu,Takeda Kenji,Iwadare Mizuho,Niwa Osamu,Masauji Tougen,Yamane Naoe,Kajinami Kouji,Kusuhara Hiroyuki,Sugiyama Yuichi

Funder

New Energy and Industrial Technology Development Organization

Grant for Collaborative Research from Kanazawa Medical University

Grants for Project Research from the High-Tech Research Center of Kanazawa Medical University

The Vehicle Racing Commemorative Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference41 articles.

1. Microdosing and other phase 0 clinical Trials: facilitating translation in drug development;Burt;Clin Transl Sci,2016

2. Novel strategies for microdose studies using non-radiolabeled compounds;Maeda;Adv Drug Deliv Rev,2011

3. Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose;Ieiri;J Clin Pharmacol,2012

4. Comparison of pharmacokinetics of newly discovered aromatase inhibitors by a cassette microdosing approach in healthy Japanese subjects;Kusuhara;Drug Metab Pharmacokinet,2017

5. Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A;Prueksaritanont;Clin Pharm Ther,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy;Clinical Biochemistry;2024-02

2. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

3. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance;European Heart Journal - Cardiovascular Pharmacotherapy;2023-05-30

4. Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease;Frontiers in Pharmacology;2023-02-27

5. Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety;Personalized Medicine;2022-11-23